Possible Benefits of Metformin for Lung Cancer Still Unknown

Tyrosine kinase inhibitors (TKI) or monoclonal antibodies (mAb) for the Treatment of NRG1 and, Potentially, NRG2 Fusion–Positive Malignancies

Vemurafenib Alone and Combination for Lung Cancer: A Conversation with Marcelo V. Negrao, MD

Premonitions About Lung Cancer for the Next Decade 

Pyrotinib: A Potential New Anti-HER2 Therapy for Lung Cancer

IASLC GENERAL DISCLAIMER

Liquid Biopsy: The Key Weapon for Real-Time Monitoring of Patients With NSCLC 

Multidisciplinary EURACAN/IASLC Proposal for Revision of the Histologic Classification of Malignant Pleural Mesothelioma 

PD-L1 Blockade Reinvigorates Dendritic Cells for Antitumor Immunity

Research’s Race to Stop a Pandemic

Improving Molecular Testing in Lung Cancer: What We Learned From the IASLC Global Survey 

Impactful Multidisciplinary Care Not Out of Reach in Community Settings